Immunome, Inc.
IMNMBiotechnology
$18.29−2.51%As of Oct 29vs prior close
- Market cap
- $2.2B
- P/E (TTM)
- –
- From 52W high
- −38.68%
- EPS (YE25)
- -$2.43
- Revenue (YE25)
- $6.9M
- Net margin
- -3059.99%
- Dividend yield
- 0.00%
Nomior Score
47
Steady ProfileSpeculativeBottom 42% of the scored universe
Growth—
Quality35
Value48
Momentum71
Resilience40
Growth
−29.63%revenue a year over 2 fiscal years
YE23 $14MYE25 $6.9M
Connections
Revenue to profitQ2 YE25
The operating loss was 1158% of revenue, narrower by 535 pts on a year.
Who owns it
2funds